

| 2-(2,6-Dichloroanilino)-2-imidazoline hydrochloride |
| Catapres |
¡Ø ÈÇиí : Clonidine hydrochloride, 98% (HPLC)
¡Ø µî±Þ : APIs and Bioactives > Adrenergic Agonists
¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 100mg , 500mg
¡Ø ÈÇÐ½Ä : C9H9Cl2N3.HCl
¡Ø CAS # : [4205-91-8]
|
| IDENTITY |
|
| CAS Registry #: |
[4205-91-8] |
| MDL Number: |
MFCD00036705 |
| MF: |
C9H9Cl2N3.HCl |
| MW: |
266.5548 |
| EINECS: |
224-121-5 |
| BRN: |
4163525 | |
| SPECIFICATIONS & PROPERTIES |
|
| Purity: |
98% (HPLC) |
| Available Spectra: |
LCMS, HPLC |
| Physical Form: |
White to off-white crystalline powder |
| Melting Point: |
>300¡ÆC |
| Long-Term Storage: |
Store long-term at 2-8¡ÆC |
| Shipping: |
Regulated for Shipping |
| UN #: |
2811 |
| Hazard Class: |
6.1 |
| Packing Group: |
I | | |
BIOLOGICAL INFO |
|
| Application(s): |
alpha-2 adrenergic agonist |
| Form: |
HCl salt |
REVIEWClonidine treats high blood pressure by stimulating a2 receptors in the brain, which decreases cardiac output and peripheral vascular resistance, lowering blood pressure. It has specificity towards the presynaptic a2 receptors in the vasomotor center in the brainstem. This binding decreases presynaptic calcium levels, and inhibits the release of norepinephrine (NE). The net effect is a decrease in sympathetic tone. It has also been proposed that the antihypertensive effect of clonidine is due to agonism on the I1-receptor (imidazoline receptor), which mediates the sympatho-inhibitory actions of imidazolines to lower blood pressure.
REFERENCES
[1] |
Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ (2010). Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol. 19;23(7):1215-22. PMID 20553011. |
| [2] |
Reitz, DJ; Piletz, JE (1997). The imidazoline receptor in control of blood pressure by clonidine and allied drugs. American Journal of Physiology 273 (5): R1569-R1571. |
Risk Description(s)
| R23: |
Toxic by inhalation. |
| R25: |
Toxic if swallowed. |
| R26: |
Very toxic by inhalation. |
Safety Description(s)
| S4: |
Keep away from living quarters. |
| S9: |
Keep container in a well-ventilated place. |
| S20: |
When using do not eat or drink. |
| S22: |
Do not breathe dust . |
| S26: |
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
| S28: |
After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer). |
| S36/37/39: |
Wear suitable protective clothing, gloves and eye/face protection. |
| S45: |
In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). |
| S60: |
This material and its container must be disposed of as hazardous waste. |


°í¾×°áÁ¦ÀÇ °æ¿ì ¾ÈÀüÀ» À§ÇØ Ä«µå»ç¿¡¼ È®ÀÎÀüȸ¦ µå¸± ¼öµµ ÀÖ½À´Ï´Ù. È®ÀΰúÁ¤¿¡¼ µµ³ Ä«µåÀÇ »ç¿ëÀ̳ª ŸÀÎ ¸íÀÇÀÇ ÁÖ¹®µî Á¤»óÀûÀÎ ÁÖ¹®ÀÌ ¾Æ´Ï¶ó°í ÆÇ´ÜµÉ °æ¿ì ÀÓÀÇ·Î ÁÖ¹®À» º¸·ù ¶Ç´Â Ãë¼ÒÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹«ÅëÀå ÀÔ±ÝÀº »óǰ ±¸¸Å ´ë±ÝÀº PC¹ðÅ·, ÀÎÅͳݹðÅ·, ÅÚ·¹¹ðÅ· ȤÀº °¡±î¿î ÀºÇà¿¡¼ Á÷Á¢ ÀÔ±ÝÇÏ½Ã¸é µË´Ï´Ù.
ÁÖ¹®½Ã ÀÔ·ÂÇÑ ÀÔ±ÝÀÚ¸í°ú ½ÇÁ¦ÀÔ±ÝÀÚÀÇ ¼º¸íÀÌ ¹Ýµå½Ã ÀÏÄ¡ÇÏ¿©¾ß Çϸç, 7ÀÏ À̳»·Î ÀÔ±ÝÀ» ÇÏ¼Å¾ß Çϸç ÀԱݵÇÁö ¾ÊÀº ÁÖ¹®Àº ÀÚµ¿Ãë¼Ò µË´Ï´Ù.
¹è¼Û ¹æ¹ý : ÅÃ¹è ¹× Á÷³³
¹è¼Û Áö¿ª : Àü±¹
¹è¼Û ºñ¿ë : ÃÑ ±¸¸Å ºñ¿ëÀÌ £Ü100,000 (VATº°µµ) ¹Ì¸¸ÀÏ °æ¿ì ÂøºÒ·Î ¹ß¼Û
¹è¼Û ±â°£ : ±¹»êǰ (3~7ÀÏ), ¼öÀÔǰ (7~14ÀÏ)
¹è¼Û ¾È³»
- »ê°£º®Áö³ª µµ¼Áö¹æÀº º°µµÀÇ Ãß°¡±Ý¾×À» ÁöºÒÇÏ¼Å¾ß ÇÏ´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù.
°í°´´Ô²²¼ ÁÖ¹®ÇϽŠ»óǰÀº ÀÔ±Ý È®ÀÎÈÄ ¹è¼ÛÇØ µå¸³´Ï´Ù. ´Ù¸¸, »óǰÁ¾·ù¿¡ µû¶ó¼ »óǰÀÇ ¹è¼ÛÀÌ ´Ù¼Ò Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù.


±³È¯ ¹× ¹ÝǰÀÌ °¡´ÉÇÑ °æ¿ì
- »óǰÀ» °ø±Þ ¹ÞÀ¸½Å ³¯·ÎºÎÅÍ 7ÀÏÀ̳»
±³È¯ ¹× ¹ÝǰÀÌ ºÒ°¡´ÉÇÑ °æ¿ì
- °í°´´ÔÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óǰµîÀÌ ¸ê½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
- Æ÷ÀåÀ» °³ºÀÇÏ¿´°Å³ª Æ÷ÀåÀÌ ÈÑ¼ÕµÇ¾î »óǰ°¡Ä¡°¡ »ó½ÇµÈ °æ¿ì
- ½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇÏ¿© ÀçÆÇ¸Å°¡ °ï¶õÇÒ Á¤µµ·Î »óǰµîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
- ¿Âµµ°ü¸®Ç° ¹× ¼öÀÔǰÀº ¹ÝǰÀÌ ºÒ°¡´ÉÇÕ´Ï´Ù.
¡Ø ÁÖ¹® Ãë¼Ò ¹× ¹ÝǰÀ¸·Î ȯºÒÀ» ¿äûÇÏ½Ç °æ¿ì¿¡´Â E-mail(info@syinnovation.co.kr) »ó´ã¼ºñ½º³ª °í°´¸¸Á·¼¾ÅÍ(070-4829-4101)¸¦ ÅëÇØ ¿äûÇϽøé Ä£ÀýÇÏ°Ô Ã³¸®ÇØ µå¸®°Ú½À´Ï´Ù.